KEGG   DRUG: Stamulumab
Entry
D05917                      Drug                                   
Name
Stamulumab (USAN)
Efficacy
Myostatin inhibitor
  Type
Monoclonal antibody
Comment
Treatment of muscular dystrophy and age-related sarcopenia or frailty
Target
MSTN [HSA:2660] [KO:K05497]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Transforming growth factors (RSTK-binding)
    MSTN
     D05917  Stamulumab (USAN)
Other DBs
CAS: 705287-60-1
PubChem: 47207575
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system